Figure 1.
Time-to-tumor recurrence (TTR) by PLS3rs6643869 and LCP14941543 in USC cohort (Training set) stage II/III CRC patients treated with 5-fluorouracil (5-FU)-based chemotherapy.
Time-to-tumor recurrence (TTR) by PLS3rs6643869 and LCP14941543 in USC cohort (Training set) stage II/III CRC patients treated with 5-fluorouracil (5-FU)-based chemotherapy.